AstraZeneca & Sputnik V COVID-19 Vaccine Combo To Enter Trial
Russians Claim The Lead In Heterologous Coronavirus Vaccination
Executive Summary
There is growing in interest in boosting the first dose of a COVID-19 vaccine by administering a different vaccine as the second dose.
You may also be interested in...
Ex-Hilleman CEO On COVID-19 Vaccine Heterologous Boosting, Endemic Disease
As more countries adopt heterologous boosting of COVID-19 vaccines in a bid to improve supplies and/or immunity while reducing side effects, vaccines expert and ex-Hilleman CEO Davinder Gill talks to Scrip in an audio interview on the challenges of the strategy and of the disease becoming endemic.
China COVID-19 Vaccines Efficacy Inadequate? Hot Debate, Variant Worries Swirl
China's regulators and spin doctors rush to remedy a comment from the nation’s top infectious disease official about the “not high” protection rate for its COVID-19 vaccines, amid debate over speedy development using mature technologies and doubts over protection in seniors. A slow roll-out is already presenting challenges to meeting an official 40% target.
Coronavirus Notebook: EU Filing For Russian Vaccine, UK Links With CureVac Against Virus Variants
There is some good news from UK and EU vaccine safety reviews, the WHO reports on COVAX vaccine distribution to less well off countries, and the European Commission and Pfizer agree on the supply of 300 million more vaccine doses.